Safety, Tolerability, and Pharmacokinetics of BAP5191 in Healthy Adults Following Topical Application of Repeat Doses
Clinical trial NCT05848453 · COMPLETED
Trial details
- NCT number
- NCT05848453
- Sponsor
- Bacoba AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-28
- Primary completion
- 2024-03-07
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.